BDBM141436 US10668051, Compound Example 100::US8921364, 100

SMILES Fc1cccc(F)c1NC(=O)c1ccc(c(F)c1)-n1nc(cc1C1CC1)C(F)(F)F

InChI Key InChIKey=BEBHBILBEVKHHU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 141436   

TargetEF-hand calcium-binding domain-containing protein 4B(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM141436(US8921364, 100 | US10668051, Compound Example 100)
Affinity DataIC50: 99.7nMT: 2°CAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat # T9033) induced endoplasmic calcium release in Jurkat cells. (see Yasu...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCalcium release-activated calcium channel protein 1(Human)
Rhizen Pharmaceuticals

US Patent
LigandPNGBDBM141436(US8921364, 100 | US10668051, Compound Example 100)
Affinity DataIC50: 99.7nMAssay Description:Inhibition of CRAC channels was determined following thapsigargin (Sigma, Cat #T9033) induced endoplasmic calcium release in Jurkat cells, (see Yasur...More data for this Ligand-Target Pair
In DepthDetails
US Patent